藤龙补中汤对大肠癌LoVo细胞失巢凋亡的作用及机制

王双双, 郑佳露, 陈锦芳, 等. 藤龙补中汤对大肠癌LoVo细胞失巢凋亡的作用及机制[J]. 中国中西医结合消化杂志, 2023, 31(9): 686-690. doi: 10.3969/j.issn.1671-038X.2023.09.06
引用本文: 王双双, 郑佳露, 陈锦芳, 等. 藤龙补中汤对大肠癌LoVo细胞失巢凋亡的作用及机制[J]. 中国中西医结合消化杂志, 2023, 31(9): 686-690. doi: 10.3969/j.issn.1671-038X.2023.09.06
WANG Shuangshuang, ZHENG Jialu, CHEN Jinfang, et al. Effects and mechanism of Tenglong Buzhong Decoction on anoikis of LoVo colorectal cancer cells[J]. Chin J Integr Tradit West Med Dig, 2023, 31(9): 686-690. doi: 10.3969/j.issn.1671-038X.2023.09.06
Citation: WANG Shuangshuang, ZHENG Jialu, CHEN Jinfang, et al. Effects and mechanism of Tenglong Buzhong Decoction on anoikis of LoVo colorectal cancer cells[J]. Chin J Integr Tradit West Med Dig, 2023, 31(9): 686-690. doi: 10.3969/j.issn.1671-038X.2023.09.06

藤龙补中汤对大肠癌LoVo细胞失巢凋亡的作用及机制

  • 基金项目:
    国家自然科学基金(No:82074352);上海市自然科学基金(No:20ZR1458700)
详细信息

Effects and mechanism of Tenglong Buzhong Decoction on anoikis of LoVo colorectal cancer cells

More Information
  • 目的 观察藤龙补中汤对人大肠癌LoVo细胞失巢凋亡的作用及机制。方法 将藤龙补中汤作用于悬浮生长的LoVo细胞,CCK-8试剂检测细胞增殖;试剂盒检测失巢凋亡、Caspases活性和活性氧;Western blot检测蛋白表达和磷酸化。结果 藤龙补中汤可以抑制LoVo细胞悬浮生长,诱导失巢凋亡,活化Caspase-3、Caspase-8和Caspase-9。Caspases抑制剂Z-VAD-FMK可拮抗藤龙补中汤对失巢凋亡的作用。藤龙补中汤可以上调活性氧生成,活性氧清除剂N-乙酰-L-半胱氨酸可拮抗藤龙补中汤对Caspases的作用。藤龙补中汤还可降低整合素αV和β3的表达,抑制黏着斑激酶的磷酸化。结论 藤龙补中汤可诱导LoVo细胞失巢凋亡,其机制可能与上调活性氧、下调整合素αV和β3的表达、抑制黏着斑激酶的磷酸化相关。
  • 加载中
  • 图 1  TBD对LoVo细胞悬浮生长的影响

    图 2  TBD对失巢凋亡的影响

    图 3  TBD对Caspases活性的影响

    图 4  TBD对活性氧的影响

    图 5  TBD对整合素-FAK信号转导的影响

  • [1]

    Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660

    [2]

    Leowattana W, Leowattana P, Leowattana T. Systemic treatment for metastatic colorectal cancer[J]. World J Gastroenterol, 2023, 29(10): 1569-1588. doi: 10.3748/wjg.v29.i10.1569

    [3]

    Khan SU, Fatima K, Malik F. Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis[J]. Clin Exp Metastasis, 2022, 39(5): 715-726. doi: 10.1007/s10585-022-10172-9

    [4]

    宝乐日, 卢艳琳, 蔡芸芸, 等. 藤龙补中汤维持治疗对大肠癌转移抑制作用的临床研究[J]. 中国中西医结合消化杂志, 2022, 30(7): 505-507, 513. https://zxyxh.whuhzzs.com/article/doi/10.3969/j.issn.1671-038X.2022.07.08

    [5]

    李淼, 王双双, 郑佳露, 等. 藤龙补中汤对SW620大肠癌转移和Wnt/β-catenin通路蛋白表达的影响[J]. 中华中医药杂志, 2022, 37(7): 4083-4085. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202207092.htm

    [6]

    王双双, 黄晓伟, 李淼, 等. 藤龙补中汤对大肠癌转移和整合素-FAK-ERK1/2通路蛋白表达的影响[J]. 中华中医药杂志, 2020, 35(4): 1697-1699. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202004021.htm

    [7]

    胡兵, 沈克平, 史秀峰, 等. 藤梨根对RKO结肠癌细胞失巢凋亡的作用[J]. 中国实验方剂学杂志, 2013, 19(16): 242-245. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201316074.htm

    [8]

    胡兵, 沈克平, 史秀峰, 等. 蛇莓对人结肠癌RKO细胞失巢凋亡作用的实验研究[J]. 世界中西医结合杂志, 2013, 8(1): 69-72. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX201301028.htm

    [9]

    Hu B, An HM, Wang SS, et al. Teng-Long-Bu-Zhong-Tang induces p21-dependent cell senescence in colorectal carcinoma LS174T cells via histone acetylation[J]. J Exp Pharmacol, 2017, 9: 67-72. doi: 10.2147/JEP.S129272

    [10]

    黄晓伟, 安红梅, 胡兵. 现代解毒抗癌中药治疗大肠癌研究进展[J]. 环球中医药, 2018, 11(11): 1838-1842. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY201811060.htm

    [11]

    Yang HL, Kuo YH, Smith ZI, et al. Targeting cancer metastasis with antibody therapeutics[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2021, 13(4): e1698. doi: 10.1002/wnan.1698

    [12]

    Chhichholiya Y, Suman P, Singh S, et al. The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies[J]. Med Oncol, 2021, 38(8): 95. doi: 10.1007/s12032-021-01547-1

    [13]

    Mina LA, Sledge GW Jr. Rethinking the metastatic cascade as a therapeutic target[J]. Nat Rev Clin Oncol, 2011, 8(6): 325-332. doi: 10.1038/nrclinonc.2011.59

    [14]

    Liu JB, Lu GZ, Liang C, et al. Roles of anoikis in colorectal cancer therapy and the assessment of anoikis-regulatory molecules as therapeutic targets[J]. Pathol Res Pract, 2023, 241: 154256. doi: 10.1016/j.prp.2022.154256

    [15]

    Sattari F, Jalilzadeh N, Mehdizadeh A, et al. Understanding and targeting anoikis in metastasis for cancer therapies[J]. Cell Biol Int, 2023, 47(4): 683-698.

    [16]

    Yu L, Wang X, Du Y, et al. FASN knockdown inhibited anoikis resistance of gastric cancer cells via P-ERK1/2/bcl-xL pathway[J]. Gastroenterol Res Pract, 2021, 2021: 6674204.

    [17]

    Zheng JL, Wang SS, Shen KP, et al. Ursolic acid induces apoptosis and anoikis in colorectal carcinoma RKO cells[J]. BMC Complement Med Ther, 2021, 21(1): 52.

    [18]

    Adeshakin FO, Adeshakin AO, Afolabi LO, et al. Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming[J]. Front Oncol, 2021, 11: 626577.

    [19]

    Hu B, Zhang T, An HM, et al. Herbal formula YGJDSJ inhibits anchorage-independent growth and induces anoikis in hepatocellular carcinoma Bel-7402 cells[J]. BMC Complement Altern Med, 2018, 18(1): 17.

    [20]

    Chen JX, Lou Q, He L, et al. Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells[J]. Int J Oncol, 2018, 52(3): 1023-1032.

    [21]

    Cai J, Niu X, Chen YY, et al. Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis[J]. Neoplasia, 2008, 10(1): 41-51.

    [22]

    Tapial Martinez P, Lopez Navajas P, Lietha D. FAK structure and regulation by membrane interactions and force in focal adhesions[J]. Biomolecules, 2020, 10(2): 179.

    [23]

    Fan Z, Duan J, Wang L, et al. PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling[J]. Cancer Lett, 2019, 450: 132-143.

    [24]

    Chuang HH, Zhen YY, Tsai YC, et al. FAK in cancer: from mechanisms to therapeutic strategies[J]. Int J Mol Sci, 2022, 23(3): 1726.

    [25]

    Tai YL, Chen LC, Shen TL. Emerging roles of focal adhesion kinase in cancer[J]. Biomed Res Int, 2015, 2015: 690690.

    [26]

    Tvaroska I, Kozmon S, Kona J. Molecular modeling insights into the structure and behavior of integrins: a review[J]. Cells, 2023, 12(2): 324.

    [27]

    Ha SY, Shin J, Kim JH, et al. Overexpression of integrin αv correlates with poor prognosis in colorectal cancer[J]. J Clin Pathol, 2014, 67(7): 576-581.

    [28]

    Sun CC, Zargham R, Shao Q, et al. Association of CD98, integrin β1, integrin β3 and Fak with the progression and liver metastases of colorectal cancer[J]. Pathol Res Pract, 2014, 210(10): 668-674.

    [29]

    Hasnat MA, Pervin M, Lim JH, et al. Apigenin attenuates melanoma cell migration by inducing anoikis through integrin and focal adhesion kinase inhibition[J]. Molecules, 2015, 20(12): 21157-21166.

    [30]

    Duxbury MS, Ito H, Zinner MJ, et al. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells[J]. Surgery, 2004, 135(5): 555-562.

  • 加载中

(5)

计量
  • 文章访问数:  753
  • PDF下载数:  107
  • 施引文献:  0
出版历程
收稿日期:  2023-01-02
刊出日期:  2023-09-15

目录